Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access.

Sewell PE, Jensen C

Open source

DOI
10.3389/fddev.2026.1906950
Published
2026
Container
Frontiers in drug delivery
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fddev.2026.1906950,
  title = {Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access.},
  author = {Sewell PE and Jensen C},
  year = {2026},
  journal = {Frontiers in drug delivery},
  doi = {10.3389/fddev.2026.1906950},
  url = {https://doi.org/10.3389/fddev.2026.1906950}
}

RIS

TY  - JOUR
TI  - Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access.
AU  - Sewell PE
AU  - Jensen C
PY  - 2026
JO  - Frontiers in drug delivery
DO  - 10.3389/fddev.2026.1906950
UR  - https://doi.org/10.3389/fddev.2026.1906950
ER  - 

APA

PE, S., & C, J. (2026). Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access.. Frontiers in drug delivery. https://doi.org/10.3389/fddev.2026.1906950

Source records